In diverse types of cancer, constitutive NFκB activity enables malignant cells to survive oncogene activation, tumor suppressors, radiation, drug treatments, extensive genetic alterations, and the surveillance of both innate and adaptive immune cells [3,5]. This evidence concerns the gene NFKB1 and neoplasm.